Tacrolimus Dose Requirement in


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
2024
Historique:
received: 04 07 2024
accepted: 20 09 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

All the factors potentially influencing tacrolimus dose requirement and combinations thereof have never been thoroughly investigated, precluding accurate prediction of tacrolimus starting dose. This prospective, non-interventional, multicenter study in

Identifiants

pubmed: 39469664
doi: 10.3389/ti.2024.13495
pii: 13495
pmc: PMC11513580
doi:

Substances chimiques

Tacrolimus WM0HAQ4WNM
Immunosuppressive Agents 0
Cytochrome P-450 CYP3A EC 1.14.14.1
Creatinine AYI8EX34EU
Bilirubin RFM9X3LJ49

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

13495

Informations de copyright

Copyright © 2024 Marquet, Anglicheau, Humeau, Adrouche, Saada, Bisiaux, Guillemin, Lardy-Cléaud and Rostaing.

Déclaration de conflit d'intérêts

SA and LS are employees of SANDOZ S.A.S, Levallois-Perret, France, which funded the study. JB, SG, and AL-C are employees of RCTs, the contract research organization that conducted the study on behalf of SANDOZ S.A.S. AH is a biostatistician at University Hospital of Limoges, France. PM, DA, and LR received honoraria from SANDOZ S.A.S as members of the study’s independent Scientific Committee. PM is a consultant/medical expert for Astellas, BMS, Chiesi, Exeltis, MedIncell, Pfizer, Siemens and Womed. DA is a consultant/medical expert for Astellas, Astra Zeneca, BMS and Chiesi. LR is a consultant/medical expert for BMS and Sanofi.

Auteurs

Pierre Marquet (P)

Department of Pharmacology, Toxicology and Pharmacovigilance, Centre Hospitalier Universitaire de Limoges, Limoges, France.
Pharmacology and Transplantation, UMR1248 Inserm Université de Limoges, Limoges, France.

Dany Anglicheau (D)

Department of Nephrology and Kidney Transplantation, Necker Hospital, Université Paris Cité, Paris, France.

Antoine Humeau (A)

Pharmacology and Transplantation, UMR1248 Inserm Université de Limoges, Limoges, France.

Sofian Adrouche (S)

Medical Department, SANDOZ S.A.S, Levallois-Perret, France.

Lakhdar Saada (L)

Medical Department, SANDOZ S.A.S, Levallois-Perret, France.

Julie Bisiaux (J)

Clinical Operations Department, RCTs, Lyon, France.

Sara Guillemin (S)

Medical Writing Department, RCTs, Lyon, France.

Audrey Lardy-Cléaud (A)

Statistical Department, RCTs, Lyon, France.

Lionel Rostaing (L)

Department of Nephrology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH